| 000 | 02352 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250526161931.0 | ||
| 008 | 250430042025xx 112 eng | ||
| 020 |
_a9781040275924 _qEA |
||
| 037 |
_bTaylor & Francis _cGBP 49.99 _fBB |
||
| 040 | _a01 | ||
| 041 | _aeng | ||
| 072 | 7 |
_aPN _2thema |
|
| 072 | 7 |
_aTDCW _2thema |
|
| 072 | 7 |
_aPS _2thema |
|
| 072 | 7 |
_aPN _2bic |
|
| 072 | 7 |
_aTDCW _2bic |
|
| 072 | 7 |
_aPS _2bic |
|
| 072 | 7 |
_aMED071000 _2bisac |
|
| 072 | 7 |
_aSCI013000 _2bisac |
|
| 072 | 7 |
_a616.8046 _2bisac |
|
| 100 | 1 |
_aNeeraj K. Sethiya _9784 |
|
| 245 | 1 | 0 | _aNatural Scaffolds for Prevention and Treatment of Neurodegenerative Disorders |
| 250 | _a1 | ||
| 260 |
_bCRC Press _c20250328 |
||
| 300 | _a400 p | ||
| 520 | _bNeurodegenerative diseases affect millions of people worldwide and are a group of several diseases with distinct pathology, physiology, prevention, and treatment strategies. Recently, natural products especially derived from medicinal plants are gaining momentum to manage neurodegenerative disease safely and effectively. Therefore, there is an urgent need to provide a ready roadmap for scientifically validated value-added nutraceutical and pharmaceutical safe and effective product for the management of various neurodegenerative diseases Natural Scaffolds for Prevention and Treatment of Neurodegenerative Disorders will provide compiled information stating several identified neurodegenerative diseases including pathology and physiology. From vast literature on natural products, such asscientifically validated plant bioactives, traditional approaches to combat or prevent neurodegenerative conditions are also included along with molecular mechanisms. The book will further specify: Single window complied information on various neurodegenerative diseases. Possible projection of bioactivity from natural resources to each category of neurodegenerative diseases. Ready-to-use reference material to develop several value-added products or proceed to the next level. The book will be very useful for nutraceutical research groups, education institutions, and industries focusing on developing value-added solutions for the management of several neurodegenerative diseases. | ||
| 700 | 1 |
_aDurgesh Nandini Chauhan _4B01 _9785 |
|
| 700 | 1 |
_aKamal Shah _4B01 _9786 |
|
| 700 | 1 |
_aNagendra Singh Chauhan _4B01 _9787 |
|
| 999 |
_c10503 _d10503 |
||